150 related articles for article (PubMed ID: 15721837)
21. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania.
Lodge R; Descoteaux A
Clin Immunol; 2005 Mar; 114(3):256-65. PubMed ID: 15721836
[TBL] [Abstract][Full Text] [Related]
22. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.
Nandan D; Knutson KL; Lo R; Reiner NE
J Leukoc Biol; 2000 Apr; 67(4):464-70. PubMed ID: 10770277
[TBL] [Abstract][Full Text] [Related]
23. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.
Palen DI; Belmadani S; Lucchesi PA; Matrougui K
Cardiovasc Res; 2005 Nov; 68(2):268-77. PubMed ID: 15967421
[TBL] [Abstract][Full Text] [Related]
24. Leishmania cell surface prohibitin: role in host-parasite interaction.
Jain R; Ghoshal A; Mandal C; Shaha C
Cell Microbiol; 2010 Apr; 12(4):432-52. PubMed ID: 19888987
[TBL] [Abstract][Full Text] [Related]
25. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
26. Proteases and phosphatases during Leishmania-macrophage interaction: paving the road for pathogenesis.
Gómez MA; Olivier M
Virulence; 2010; 1(4):314-8. PubMed ID: 21178462
[TBL] [Abstract][Full Text] [Related]
27. Molecular architecture of leishmania EF-1alpha reveals a novel site that may modulate protein translation: a possible target for drug development.
Lopez M; Cherkasov A; Nandan D
Biochem Biophys Res Commun; 2007 May; 356(4):886-92. PubMed ID: 17397800
[TBL] [Abstract][Full Text] [Related]
28. The role of mannose receptor during experimental leishmaniasis.
Akilov OE; Kasuboski RE; Carter CR; McDowell MA
J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
30. SHP protein tyrosine phosphatase expression in rat uterine tissue.
Phillippe M; Bradley DF; Engle D; Sweet L
J Soc Gynecol Investig; 2006 Jul; 13(5):338-42. PubMed ID: 16814162
[TBL] [Abstract][Full Text] [Related]
31. Selective targeting of indel-inferred differences in spatial structures of highly homologous proteins.
Cherkasov A; Nandan D; Reiner NE
Proteins; 2005 Mar; 58(4):950-4. PubMed ID: 15657927
[TBL] [Abstract][Full Text] [Related]
32. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
33. Design and biological evaluation of linear and cyclic phosphopeptide ligands of the N-terminal SH2 domain of protein tyrosine phosphatase SHP-1.
Imhof D; Wieligmann K; Hampel K; Nothmann D; Zoda MS; Schmidt-Arras D; Zacharias M; Böhmer FD; Reissmann S
J Med Chem; 2005 Mar; 48(5):1528-39. PubMed ID: 15743195
[TBL] [Abstract][Full Text] [Related]
34. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
[TBL] [Abstract][Full Text] [Related]
36. SHP-2 positively regulates adipogenic differentiation in 3T3-L1 cells.
Uehara T; Suzuki K; Yamanaka H; Kizaki T; Sakurai T; Ishibashi Y; Ishida H; Ohno H
Int J Mol Med; 2007 Jun; 19(6):895-900. PubMed ID: 17487421
[TBL] [Abstract][Full Text] [Related]
37. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of normal and neoplastic human mast cells for expression of CD172a (SIRPalpha), CD47, and SHP-1.
Florian S; Ghannadan M; Mayerhofer M; Aichberger KJ; Hauswirth AW; Schernthaner GH; Printz D; Fritsch G; Böhm A; Sonneck K; Krauth MT; Müller MR; Sillaber C; Sperr WR; Bühring HJ; Valent P
J Leukoc Biol; 2005 Jun; 77(6):984-92. PubMed ID: 15784688
[TBL] [Abstract][Full Text] [Related]
39. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-gamma-primed macrophages.
Flandin JF; Chano F; Descoteaux A
Eur J Immunol; 2006 Feb; 36(2):411-20. PubMed ID: 16369915
[TBL] [Abstract][Full Text] [Related]
40. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages.
Silverman JM; Clos J; de'Oliveira CC; Shirvani O; Fang Y; Wang C; Foster LJ; Reiner NE
J Cell Sci; 2010 Mar; 123(Pt 6):842-52. PubMed ID: 20159964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
